{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-26-000014","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.684165+00:00","generated_at":"2026-05-16T00:49:21.061262+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evolent Q4 2025 revenue $468.7M, net loss $429.1M; guides 2026 revenue up ~30%","bullets":["Q4 2025 revenue $468.7M, full-year $1.876B. Net loss $429.1M Q4, $579.4M full year.","Adjusted EBITDA $37.8M (8.1% margin) Q4; $151.2M (8.1% margin) full year.","Performance Suite average members 6,482 for year; $900M new Performance Suite revenue for 2026.","2026 revenue growth guidance ~30%; first-half Adj. EBITDA pressured by reservering and membership declines.","Medical expense ratio 90.2% Q4; 80.5% full year (excl. ECP 94.8% and 89.0%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-26-000014","json":"https://secwatch.observer/filing/0001628908-26-000014.json","markdown":"https://secwatch.observer/filing/0001628908-26-000014.md","text":"https://secwatch.observer/filing/0001628908-26-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000014/0001628908-26-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000014/evh-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:49:21.061262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}